←
Francis (Frank) Farraye, MD, MSc96 posts
Francis (Frank) Farraye, MD, MSc avatar

Francis (Frank) Farraye, MD, MSc

@FarrayeIBD

Gastroenterologist at @MayoClinic with expertise in the diagnosis and treatment of #IBD. Tweets are my own. #MayoClinicFL

◷ Joined December 2015▧ 2 Photos and videos
Jana G Hashash, MD, MSc avatar
⟳ Francis (Frank) Farraye, MD, MSc retweeted
Jana G Hashash, MD, MSc@JHashashMD·23 Aug 2025

Thank you @DDS_Journal for highlighting our work on BAS & pouchitis @AlsakarnehSaqr @FarrayeIBD ✅BAS not inferior to abx in nonresponse or early relapse (aOR=0.94, p=0.34) ✅ BAS ⬇️ recurrent pouchitis (aHR: 0.57; p<0.001) and ⬆️ time to recurrent pouchitis (p<0.001)

Alsakarneh et al retrospectively studied the response of patients with pouchitis and resulting from IBD surgery, finding that treatment with bile acid sequestrants was noninferior or possibly superior to the current standard, antibiotic treatment. bit.ly/4mUEVoz

Post attachment
Healio Gastroenterology avatar
⟳ Francis (Frank) Farraye, MD, MSc retweeted
Healio Gastroenterology@HealioGastro·2 Jul 2025

🩺💉 New @AmCollegeGastro guideline urges GI docs to promote preventive care — like vaccines & screenings — for #IBD patients.   Many patients see their GI as a de facto #PrimaryCare provider, say @FarrayeIBD & colleagues. #PreventiveCare #GITwitter bit.ly/44tkyHv

Edward Loftus avatar
⟳ Francis (Frank) Farraye, MD, MSc retweeted
Edward Loftus@EdwardLoftus2·15 Jun 2025

Patients with Crohn’s Disease and Ileostomy Can Respond to Upadacitinib | Digestive Diseases and Sciences ⁦@LaurenLoebMD⁩ ⁦@ibdgijami⁩ ⁦@ibdgijami⁩ ⁦@JHashashMD⁩ ⁦@FarrayeIBD⁩ link.springer.com/article/10…

BIDMC_GI avatar
⟳ Francis (Frank) Farraye, MD, MSc retweeted
BIDMC_GI@BIDMC_GI·11 Jun 2025

Such a pleasure to host Francis A. Farraye, MD, MSc, today for GI Grand Rounds as we celebrated our fourth annual Peppercorn Lectureship, named for Dr. Mark Peppercorn! We all enjoyed learning from Dr. Farraye's talk, "Health Maintenance for Patients with IBD." 🌟

Post attachment
Saqr Alsakarneh, MD, MS avatar
⟳ Francis (Frank) Farraye, MD, MSc retweeted
Saqr Alsakarneh, MD, MS@AlsakarnehSaqr·7 Apr 2025

Hot of the press 🚨 Just published in @APandT our study on risk of new onset #IBD in patients taking IL-17 inhibitors 💊 🔑 findings: 📌 Patients on anti-IL-17 are at increased risk of de novo IBD (aHR: 2.5) 📌 Risk was elevated for both UC and CD 📌Number needed to harm (NNH=161) 📌Secukinumab was associated with highest risk (aHR=2.82) Full 📖: onlinelibrary.wiley.com/doi/…… @FarrayeIBD @JHashashMD @OmarAlTaanii @RazanAburummann @AmCollegeGastro @AmerGastroAssn @CrohnsColitisFn @ACPIMPhysicians @ACRheum #GITwitter #MedTwitter

Post attachmentPost attachment
Jami Kinnucan, MD, FACG, AGAF, FCCF avatar
⟳ Francis (Frank) Farraye, MD, MSc retweeted
Jami Kinnucan, MD, FACG, AGAF, FCCF@ibdgijami·15 Nov 2024

#IBD patients want to know… What they can do in addition to starting effective medical therapy for their inflammation 🚭 avoid smoking 🍽️Diet: Mediterranean diet 🍆🥑🍓🥦 🚫NSAID 🎯Normal BMI 🏃🏽‍♀️Get active 😊Focus on mental health 👶Discuss contraception @AshwinMDIBD

Post attachment